Patent litigation: There’s a lot of it, but not all of it is created equal. So says the “Patent Litigation Damages Report,” the first edition of a study that Menlo Park, Calif.-based legal analytics company Lex Machina released Wednesday.
The study looked at all 36,629 patent cases filed and terminated in the U.S. from 2000 to 2013. The majority of cases involved patent disputes over technology, pharmaceuticals and genetically modified organisms (GMOs).
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
